Trialect

+ More Filters

Reset Filters

Specialty

Funding Organization

Funding Type

Eligible Country

Deadline

From

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

APDA Diversity in PD Research Grant with LOI

American Parkinson Disease Association

Letter of Intent due: Dec 16, 2024.

Invitation for full application: Early February 2025

Full Application due: April 2025

Award details

One year grant up to a maximum of $75,000 will be awarded to research scientists (MD, MD/PhD, or PhD).

The applicants will receive notification of the decision in June 2024. The APDA grant year runs from September 1st, 2025, to August 31st, 2026.

Goal

APDA Diversity in PD Research Grant is a one-year grant to study the health inequities and/or differences among under-studied PD communities, across the spectrum of ethnicity, ancestry, geography, socioeconomic conditions, and gender. Current research has established the following:

Diagnosis of PD among some under-studied communities is delayed.
Some under-studied communities are less likely to receive quality PD care.
Clinical trial enrollment among certain under-studied communities does not match their representation in the population.
Differences in clinical features, response to treatment, co-morbidities, prevalence, natural history, genetics and biomarkers among various under-studied PD populations have not been fully explored.

Projects should address one of these four issues. Projects can be designed to detect inequities or differences, understand the reasons for the inequities or differences, or test an intervention to improve disparities.

Application Process and Proposal

Required information in the Letter of Intent:

Provide an overview of research activities to be carried out. You can upload figures in supplemental materials. (400 words)
Highlight the novelty of the current research as well as the relevance and potential significance of the findings to the PD community (100 words)
Indicate collaborations with other internal or external researchers/organizations. (50 words)
Explain why your institution and your lab are equipped to perform this research (100 words)
Provide a narrative of how the budget will be allocated (% personnel, % equipment, etc.) (50 words)
Citations (unlimited)

In addition, the applicant’s NIH biosketch is required.

Funding

10% of the funding can be used for indirect costs

Funding is not to be used for:

Travel expenses.
Publication costs higher than $1,000.
Equipment costs higher than $8,000.

Grant Disbursement

Funds will be awarded as follows:

50% on or about September 2025.
25% on receipt of an acceptable six (6) month scientific report.
25% on receipt of acceptable twelve (12) month scientific and financial reports.

Specialties

Neurosciences

Eligibility Requirements

All research scientists in the field of Parkinson’s research can apply, including those from outside the US.

Sponsor Details

Sponsor Institute/Organizations: American Parkinson Disease Association

Address: PO Box 61420 Staten Island, NY 10306 TEL: 800-223-2732 FAX: 718-981-4399

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity